Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $1.07 Million - $1.54 Million
-18,600 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$72.92 - $102.01 $145,840 - $204,020
2,000 Added 12.05%
18,600 $1.9 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $180,740 - $244,980
-2,000 Reduced 10.75%
16,600 $1.5 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $617,619 - $814,476
-6,900 Reduced 27.06%
18,600 $2.2 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $619,800 - $965,000
-10,000 Reduced 28.17%
25,500 $2.21 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $338,030 - $564,200
-7,000 Reduced 16.47%
35,500 $2.8 Million
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $378,400 - $699,599
10,000 Added 30.77%
42,500 $2.54 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $464,900 - $605,100
-10,000 Reduced 23.53%
32,500 $1.71 Million
Q3 2017

Nov 13, 2017

BUY
$37.05 - $47.12 $1.57 Million - $2 Million
42,500
42,500 $2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.